Article Text

other Versions

PDF
C-reactive protein for risk assessment in coronary artery disease
  1. Nicolas Danchin*
  1. 1 Hôpital européen Georges Pompidou and Université René Descartes-Paris 5, France
  1. Correspondence to: Nicolas Danchin, Coronary Artery Disease, HEGP, 20 rue Leblanc, Paris, 75015, France; nicolas.danchin{at}egp.aphp.fr

Abstract

As in many other fields of human activity, medicine is subject to fashion, and in recent years much attention has been given to C-reactive protein (CRP). Numerous studies have described CRP as a risk marker for coronary artery disease (CAD) in the general population, with some even suggesting that CRP could be a true risk factor for CAD, while other studies have described CRP as a major prognostic stratification tool in patients with known CAD. In short, CRP tends to be presented as the alpha and omega of coronary artery disease.

Statistics from Altmetric.com

Footnotes

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Linked Articles